BASSO CAPITAL MANAGEMENT, L.P. - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 33 filers reported holding IBERE PHARMACEUTICALS in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BASSO CAPITAL MANAGEMENT, L.P. ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q3 2022$4,0000.0%52,7020.0%0.00%–
Q2 2022$4,000
-63.6%
52,7020.0%0.00%
-100.0%
Q1 2022$11,000
-60.7%
52,7020.0%0.00%
-66.7%
Q4 2021$28,000
-12.5%
52,7020.0%0.00%
-25.0%
Q3 2021$32,000–52,702–0.00%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q4 2021
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 9,800$108,0540.10%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders